Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you're ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

(CDC) notes that a person who develops emphysema alongside chronic bronchitis will receive a diagnosis of COPD. This is a serious and potentially life threatening condition.

Merck to acquire respiratory drug maker, Verona Pharma for $10 billion: Rahway, New Jersey Thursday, July 10, 2025, 09:00 Hrs [IST] Merck, known as MSD outside of the United State ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

So what is an exacerbation of COPD, or exacerbation of chronic bronchitis? Basically, it is based on a symptomatic definition. The patient complains about an increase in the baseline symptoms of ...

Chronic bronchitis causes inflammation in the airways and excess mucus production, while emphysema damages the air sacs (alveoli) in the lungs that are essential for oxygen absorption.

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution.

New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th ...

Chronic bronchitis causes ongoing inflammation of the airways. It is a type of chronic obstructive pulmonary disease (COPD).